share_log

The Three-year Shareholder Returns and Company Earnings Persist Lower as AK Medical Holdings (HKG:1789) Stock Falls a Further 7.7% in Past Week

The Three-year Shareholder Returns and Company Earnings Persist Lower as AK Medical Holdings (HKG:1789) Stock Falls a Further 7.7% in Past Week

由于爱康医疗控股(HKG:1789)股价上周进一步下跌7.7%,公司的三年股东回报和收益仍然较低。
Simply Wall St ·  06/19 20:20

The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the last three years have been particularly tough on longer term AK Medical Holdings Limited (HKG:1789) shareholders. So they might be feeling emotional about the 68% share price collapse, in that time. And the ride hasn't got any smoother in recent times over the last year, with the price 28% lower in that time. Even worse, it's down 20% in about a month, which isn't fun at all.

事实是,如果你投资时间足够长,你最终会遇到一些亏损的股票。但是,最近三年对长期持有爱康医疗控股有限公司(HKG:1789)股票的股东来说特别艰难。所以,他们可能对在这段时间内68%的股价跌幅感到情绪低落。而且,在过去的一年中,股价下跌28%,情况变得更加复杂。更糟糕的是,在约一个月的时间内下跌了20%,这一点也不有趣。

With the stock having lost 7.7% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.

由于在过去一周中股票已经下跌了7.7%,因此值得检查业务绩效,看看是否存在任何红旗信号。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

在他的文章《格雷厄姆和多德斯维尔超级投资者》中,沃伦·巴菲特描述了股票价格并不总是反映公司价值的合理方式。考虑市场对公司的看法如何发生变化的一个不完美但简单的方法是将每股收益(EPS)的变化与股价的变动进行比较。股票价格并不总是反映公司价值的合理方式在股价上涨的5年中,新加坡交易所由亏损逐渐转为盈利。而在之后的12个月内,该公司的财务报表则呈亏损状态,这表明它的盈利能力不可靠。其他指标可能会更好地反映公司的价值变化。

AK Medical Holdings saw its EPS decline at a compound rate of 17% per year, over the last three years. This reduction in EPS is slower than the 31% annual reduction in the share price. So it seems the market was too confident about the business, in the past.

过去三年中,爱康医疗控股每股收益下降了17%的复合率。这种每股收益的减少速度比股价每年下降31%的速度要慢。因此,看来市场过去过于自信了这个企业。

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

您可以在下面的图片中查看每股收益如何随时间变化(单击图表以查看确切的价值)。

earnings-per-share-growth
SEHK:1789 Earnings Per Share Growth June 20th 2024
SEHK:1789每股收益增长 2024年6月20日

We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. It might be well worthwhile taking a look at our free report on AK Medical Holdings' earnings, revenue and cash flow.

我们很高兴地报告,该公司的CEO获得的薪酬比同等资本化公司的大多数CEO都要适度。关注CEO薪酬总是值得的,但更重要的问题是公司是否能够在多年中增加收益。这可能是值得一看的地方,我们有关于爱康医疗控股的收益、营业收入和现金流的免费报告。

A Different Perspective

不同的观点

While the broader market gained around 3.0% in the last year, AK Medical Holdings shareholders lost 28% (even including dividends). However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 3% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand AK Medical Holdings better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with AK Medical Holdings , and understanding them should be part of your investment process.

尽管市场整体上一年涨了约3.0%,爱康医疗控股的股东们还是亏损了28%(包括分红)。然而,请记住,即使最好的股票有时也会在十二个月的时间内表现不佳。好消息是,长期股东已经赚了钱,过去五年平均每年增长3%。最近的抛售可能是一个机会,因此值得检查基本数据是否显示出长期增长趋势的迹象。在更长的时间里跟踪股价表现总是很有趣的。但要更好地了解爱康医疗控股,我们需要考虑许多其他因素。例如,不断存在的投资风险。我们已经确定了一项警告信号,需要了解他们应该成为你的投资过程的一部分。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).

如果您喜欢与管理层一起购买股票,那么您可能会喜欢这个公司的免费列表。 (提示:其中许多公司不为人注意且具有吸引力的估值。)

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Hong Kong exchanges.

请注意,本文引用的市场回报反映了当前在香港证券交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发